|
|
||||||||
J Thorac Cardiovasc Surg 2004;128:220-232
© 2004 The American Association for Thoracic Surgery
Cardiopulmonary support and physiology |
a Department of Cardiac Surgery, Children's Hospital, 300 Longwood Ave, Boston, MA USA
b Biostatistics, Children's Hospital, 300 Longwood Ave, Boston, MA USA
c Department of Pathology, Children's Hospital, 300 Longwood Ave, Boston, MA USA
d Department of Neurology, Children's Hospital, 300 Longwood Ave, Boston, MA USA
e Department of Animal Resource, Children's Hospital, 300 Longwood Ave, Boston, MA USA
f Department of Anesthesia, Children's Hospital, 300 Longwood Ave, Boston, MA USA
g Department of Surgery, Harvard Medical School, Boston, MA USA
h Department of Pathology, Harvard Medical School, Boston, MA USA
i Department of Neurology, Harvard Medical School, Boston, MA USA
j Department of Aneshesia, Harvard Medical School, Boston, MA USA
Read at the Third World Congress of Pediatric Cardiology and Cardiac Surgery, Toronto, Canada, May 28-31, 2001.
Received for publication April 23, 2002; revisions received October 28, 2003; accepted for publication November 8, 2003.
* Address for reprints: Richard A. Jonas, MD, Department of Cardiac Surgery, Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA
Richard.jonas{at}tch.harvard.edu
OBJECTIVE: Previous studies have demonstrated that both hematocrit level and pH influence the protection afforded by deep hypothermic circulatory arrest. The current study examines how temperature modulates the effect of hematocrit level and pH in determining a safe duration of circulatory arrest. The study also builds on previous work investigating the utility of near-infrared spectroscopy as a real-time monitor of cerebral protection during circulatory arrest.
METHODS: Seventy-six piglets (9.3 ± 1.2 kg) underwent circulatory arrest under varying conditions with continuous monitoring by means of near-infrared spectroscopy (hematocrit level of 20% or 30%; pH-stat or alpha-stat strategy; temperature of 15°C or 25°C; arrest time of 60, 80, or 100 minutes). Neurologic recovery was evaluated daily by a veterinarian, and the brain was fixed in situ on postoperative day 4 to be examined on the basis of histologic score in a blinded fashion.
RESULTS: Multivariable analysis of total histologic score revealed that higher temperature, lower hematocrit level, more alkaline pH, and longer hypothermic circulatory arrest duration were predictive of more severe damage to the brain (P < .01). Regression modeling revealed that higher temperature exacerbated the disadvantage of a lower hematocrit level and longer arrest times but not pH strategy. Normalized oxyhemoglobin nadir time, derived from near-infrared spectroscopy, was positively correlated with neurologic recovery on the fourth postoperative day and with total histologic injury score (P < .0001).
CONCLUSION: Hematocrit level and pH, as well as temperature, determine the safe duration of hypothermic circulatory arrest. Near-infrared spectroscopy is a useful real-time monitor of safe duration of circulatory arrest.
This article has been cited by other articles:
![]() |
G. Wernovsky Improving neurologic and quality-of-life outcomes in children with congenital heart disease: Past, present, and future J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 240 - 242. [Full Text] [PDF] |
||||
![]() |
D. Wypij, R. A. Jonas, D. C. Bellinger, P. J. Del Nido, J. E. Mayer Jr., E. A. Bacha, J. M. Forbess, F. Pigula, P. C. Laussen, and J. W. Newburger The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Halstead, C. Etz, D. M. Meier, N. Zhang, D. Spielvogel, D. Weisz, C. Bodian, and R. B. Griepp Perfusing the Cold Brain: Optimal Neuroprotection for Aortic Surgery Ann. Thorac. Surg., September 1, 2007; 84(3): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Halstead, M. Wurm, D. M. Meier, N. Zhang, D. Spielvogel, D. Weisz, C. Bodian, and R. B. Griepp Avoidance of hemodilution during selective cerebral perfusion enhances neurobehavioral outcome in a survival porcine model Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Williams and C. Ramamoorthy Brain monitoring and protection during pediatric cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 23 - 33. [Abstract] [PDF] |
||||
![]() |
T. Miura, T. Sakamoto, M. Kobayashi, T. Shin'oka, and H. Kurosawa Hemodilutional anemia impairs neurologic outcome after cardiopulmonary bypass in a piglet model J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 29 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakamoto, T. Asou, Y. Takeda, K. Date, and M. Nanaumi Long-Term Outcome of Intracardiac Repair Under Simple Deep Hypothermia Asian Cardiovasc Thorac Ann, December 1, 2006; 14(6): 458 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Olsson and S. Thelin Regional cerebral saturation monitoring with near-infrared spectroscopy during selective antegrade cerebral perfusion: Diagnostic performance and relationship to postoperative stroke J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 371 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Newburger and D. C. Bellinger Brain Injury in Congenital Heart Disease Circulation, January 17, 2006; 113(2): 183 - 185. [Full Text] [PDF] |
||||
![]() |
M. Ricci, P. Lombardi, A. Galindo, E. Coscarella, A. Vasquez, and E. Rosenkranz Single-Ventricle Physiology Reduces Cerebral Oxygen Delivery in a Piglet Model Ann. Thorac. Surg., August 1, 2005; 80(2): 686 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hagino, V. Anttila, D. Zurakowski, L. F. Duebener, H. G.W. Lidov, and R. A. Jonas Tissue oxygenation index is a useful monitor of histologic and neurologic outcome after cardiopulmonary bypass in piglets J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 384 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Jonas Hematocrit trial J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1200 - 1200. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |